Profit taking weighs down Fate Therapeutics By: MarketMinute.com Stock News December 28, 2017 at 17:49 PM EST Investors locked in profits on Fate Therapeutics Inc. (Nasdaq: FATE). The stock price lost 55 cents to close at $6.09. Related Stocks: Fate Therapeutics